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Abstract
Background: The purpose of this study was to ascertain multimorbidity patterns using a non-hierarchical cluster
analysis in adult primary patients with multimorbidity attended in primary care centers in Catalonia.
Methods: Cross-sectional study using electronic health records from 523,656 patients, aged 45–64 years in 274
primary health care teams in 2010 in Catalonia, Spain. Data were provided by the Information System for the
Development of Research in Primary Care (SIDIAP), a population database. Diagnoses were extracted using
241 blocks of diseases (International Classification of Diseases, version 10). Multimorbidity patterns were identified using
two steps: 1) multiple correspondence analysis and 2) k-means clustering. Analysis was stratified by sex.
Results: The 408,994 patients who met multimorbidity criteria were included in the analysis (mean age, 54.2 years
[Standard deviation, SD: 5.8], 53.3% women). Six multimorbidity patterns were obtained for each sex; the three most
prevalent included 68% of the women and 66% of the men, respectively. The top cluster included coincident diseases
in both men and women: Metabolic disorders, Hypertensive diseases, Mental and behavioural disorders due to
psychoactive substance use, Other dorsopathies, and Other soft tissue disorders.
Conclusion: Non-hierarchical cluster analysis identified multimorbidity patterns consistent with clinical practice,
identifying phenotypic subgroups of patients.
Keywords: Multimorbidity, Cluster analysis, Multiple correspondence analysis, K-means clustering, Primary
health care, Electronic health records, Diseases
Background
In the first decade of the twenty-first century, tremendous
effort was concentrated on surfacing data about multimor-
bidity patterns in order to increase the knowledge of how
the diseases were clustered [1–3]. In everyday primary care
settings, multimorbidity is more the norm than an excep-
tion, with a prevalence ranging from 13 to 95% in the global
population, depending on the age group included and meth-
odology used [2]. Therefore, establishing these clustered as-
sociations could inform Clinical Practice Guidelines (CPG)
and guide decision-making in the clinical practice [4].
No consensus has been established about a standard
model to determine multimorbidity patterns. Differences
between studies have been observed, such as the unit of
analysis selected (patients versus diseases), the statistical
method for grouping diseases (factor analysis vs. cluster
analysis), diseases included (chronic or all), and number
of diseases included in the models [1, 5].
To identify the multimorbidity patterns, methods that
identify and separate certain population groups from
others and study non-random associations between dis-
eases in those sub-groups are needed [3, 6]. There are
basically two statistical methods for grouping diseases:
factor analysis and cluster analysis. Exploratory factor
analysis is based on correlations between diagnoses to
identify the patterns; it is used to test hypothesised
relationships between observed measures and latent
constructs and allows the inclusion of a diagnosis in
multiple factors. In contrast, cluster analysis obtains the
patterns of multimorbidity based on dissimilarities be-
tween diseases; clusters tend to contain diagnoses that
are similar to each other (in terms of Euclidean
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distances) and a diagnosis cannot be included in more
than one cluster. Usually, factor analysis is used to study
diseases and cluster analysis to study patients [7]. A
recent comparison of the two methods concluded that
cluster analysis is more useful than factor analysis for
in-depth study of multimorbidity patterns [8].
Among cluster analysis methods, there are two main
types of techniques: hierarchical (HCA) and non-hierarch-
ical cluster analysis (NHCA) [9]. The first, often
considered when choosing a clustering technique in bio-
medicine, attempts to identify relatively homogeneous
groups of cases based on selected characteristics, using an
algorithm that either agglomerates or divides entities to
form clusters. HCA is organized so that one cluster can be
entirely contained within another cluster, but no other
kind of overlap between clusters is allowed. However, the
technique is not particularly good when it comes to robust
identification of patterns in data. The main limitations are
that the hierarchical clusters are susceptible to outliers in
the data, the final solution depends on the chosen distance
measure, and the algorithms are not efficient to analyse
large data sets, as they require a large distance matrix.
Nevertheless, almost all studies to date have used HCA to
analyse multimorbidity patterns [2, 3].
Among the NHCA methods, K-means is the most fre-
quently used. In contrast to HCA, this approach does
not involve the construction of groups via iterative div-
ision or clustering; instead, patients are assigned to clus-
ters once the number of clusters is specified. The results
are less susceptible to outliers in the data, to the influ-
ence of choosing a distance measure, or to the inclusion
of inappropriate or irrelevant variables. Algorithms that
do not require a distance matrix, such as k-means, can
analyse extremely large data sets [9–11].
The study of biological heterogeneity requires the identi-
fication of subgroups of populations with specific combina-
tions of coexisting diseases. This “multimorbidity patient”
approach identifies phenotypes of the subgroups, describes
the patterns of diseases within each one, and facilitates the
development of more targeted patient management [12].
The purpose of this study was to obtain the multimor-
bidity patterns in adult patients with multimorbidity
attended in primary care in Catalonia (Spain), stratified
by sex, using a k-means cluster analysis.
Methods
Design, setting and study population
A cross-sectional study was conducted in Catalonia (Spain),
a Mediterranean region with 7,434,632 inhabitants, 81% of
which live in urban municipalities (2010 census). The
Spanish National Health Service (NHS) provides universal
coverage, financed mainly by tax revenue. The Catalan
Health Institute (CHI) manages primary health care teams
(PHCTs) that serve 5,501,784 patients (274 PHCT), or 74%
of the population; the remaining PHCTs are managed by
other providers.
The CHI’s Information System for the Development of
Primary Care Research (SIDIAP) contains the coded
clinical information recorded in electronic health re-
cords (EHR) by its 274 PHCTs since 2006. A subset of
SIDIAP records meeting the highest quality criteria for
clinical data, the SIDIAP-Q, includes 1,833,125 patients
attended by the 1365 general practitioners (GPs).
SIDIAP Q represents 40% of the SIDIAP population
whose data recording scores contain information on the
majority of the population of Catalonia, and is highly
representative of the whole region in terms of geog-
raphy, age, sex, and diseases. This study was limited to
SIDIAP-Q, as the sample was representative of the
population [13].
Prevalence of individual conditions, multimorbidity,
and disease patterns varies by age. To obtain a more
homogenous sample of multimorbidity, we identified
408,944 patients with multimoribidity aged 45 to 64 years
[14] on 31 December 2010 (Additional file 1).
Coding and selection of diseases
Diseases are coded in SIDIAP using International Classi-
fication of Diseases version 10 (ICD-10) [15]. For this
study, we selected all active diagnoses recorded in EHR
as of December 31, 2010, except for R codes (symptoms,
signs, and abnormal clinical and laboratory findings, not
elsewhere classified) and Z codes (factors influencing
health status and contact with health services). Of the
263 blocks of diagnosis in the ICD-10, excluding the R
codes and Z codes yielded 241 blocks. Non-active diag-
noses, based on the presence of an end date in the EHR,
were excluded. These diagnoses covered a broad list of
acute diseases for which the system automatically assigns
an end date (e.g., 60 days after the initial diagnosis).
To facilitate information management, the diagnoses
were extracted using the 263 blocks (disease categories)
in the ICD-10 structure. These are homogeneous cat-
egories of very closely related specific diagnoses. For ex-
ample, Hypertensive diseases include Essential (primary)
hypertension, Hypertensive heart disease, Hypertensive
renal disease, Hypertensive heart and renal disease, and
Secondary hypertension. To obtain consistent and
clinically interpretable patterns of association, and to
avoid spurious relationships that could bias the re-
sults, we considered only diagnoses with greater than
1% prevalence in each sex. All patients with multi-
morbidity were included.
Multimorbidity definition
Multimorbidity was defined by the presence of two or
more ICD-10 diagnoses in the EHR from the 241 blocks
selected.
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Variables
The unit of measurement was the diagnoses included in
the 241 blocks (disease categories) of the ICD-10 struc-
ture (values: 1 if present, 0 if absent). Other variables re-
corded were number of diseases, age (in years), and sex
(women, men).
No missing values were handled, as sex and age were
recorded for all patients. Wrong sex-specific diagnosis
codes and diagnoses with inconsistent dates were ex-
cluded during data cleaning. Any record with no disease
diagnoses was considered as a disease-free individual.
Statistical analysis
Analyses were stratified by sex. Descriptive statistics
were used to summarize overall information. Categorical
variables were expressed as frequencies (percentage) and
continuous variables as mean (Standard deviation, SD)
or median (interquartile range, IQR). Two sample tests
of proportions were used to assess sex-based differences
between groups Mann Whitney was used to test the
non-normally distributed variable of number of blocks
of diagnoses by sex.
We identified disease patterns using two steps:
1) Multiple Correspondence Analysis (MCA): A data
analysis technique for nominal categorical data, was
used to detect and represent underlying structures
in the data set. The method allows representation in
a multidimensional space of relationships between a
set of dichotomous or categorical variables (in our
case, diagnoses) that would otherwise be difficult to
observe in contingency tables and show groups of
patients with the same characteristics [16]. MCA
also allows direct representation of patients as points
(coordinates) in geometric space, transforming
the original binary data to continuous data
(Additional file 2). The MCA analysis was based
on the indicator matrix. Optimal number of
dimensions extracted and percentages of inertia
were determined by the means of scree plot.
2) K-means clustering: From the geometric space created
in MCA, patients were classified into clusters
according to proximity criteria by means of the
k-means algorithm. The algorithm is composed
of the following steps: 1) Place K points into the
space represented by the patients that are being
clustered. These points represent initial group
centroids. 2) Assign each patient to the group that
has the closest centroid. 3) When all patients have
been assigned, recalculate the positions of the K
centroids. Repeat Steps 2 and 3 until the centroids no
longer move. This produces a separation of the
patients into homogenous groups while maximizing
heterogeneity across groups [9]. The optimal number
of clusters is the solution with the highest Calinski-
Harabasz index value. To assess internal cluster
quality, cluster stability of the optimal solution
was computed using Jaccard bootstrap values with
100 runs [17]. Highly stable clusters should yield
average Jaccard similarities of 0.85 and above [9].
Statistics of multimorbidity patterns
To describe the multimorbidity patterns in patients, fre-
quencies and percentages of diseases in each cluster
were calculated. Observed/expected ratios (“O/E-ratios”)
were calculated by dividing disease prevalence in the
cluster by disease prevalence in the sex group. A disease
was considered to be associated with the multimorbidity
pattern when O/E-ratio was ≥2 [18]. Exclusivity, defined
as the fraction of patients with the disease included in
the cluster over the total strata patients with the disease,
was also calculated. To describe the relative position of
the clusters, centrality defined as the distance of the
cluster centroid to the origin was calculated. Descriptive
statistics of age and the median number of diagnoses for
each cluster were also obtained. Clinical criteria were
used to evaluate the consistency and utility of the final
cluster solution. To reduce the size of the tables, only
groups of diseases with a prevalence higher than 10% in
the cluster were shown.
The analyses were carried out using SPSS for Windows,
version 18 (SPSS Inc., Chicago, IL, USA) and R version
3.3.1 (R Foundation for Statistical Computing, Vienna,
Austria).
Results
Out of 523,656 patients aged 45 to 64 years, 408,994
(78.1%) met the multimorbidity criteria. Women had a
higher multimorbidity prevalence than men (82.2% vs.
73.9%, p < 0.001). The mean age was 54.2 years (Stand-
ard deviation [SD]: 5.8), 53.3% were women, and the
mean number of diagnoses per patient was 5.7 (SD: 3.3).
The analysis included 217,823 women and 191,171 men
with 79 and 73 different diagnoses, respectively (Table 1
and Additional file 3).
Data were transformed using MCA (Additional file 2).
K-means clustering using Calinski criterion to obtain six
clusters was considered the optimal solution for both
women and men. Average Jaccard bootstrap values for
women and men were 0.98 and 0.90, respectively, show-
ing highly stable solutions. A spatial representation of
clusters is shown with a cluster plot for women (Fig. 1a)
and men (Fig. 1b).
Six multimorbidity patterns were obtained for each
sex. The three most prevalent multimorbidity patterns
included 68.4% of women patients (Table 2) and 65.6%
of men patients (Table 3). The number of diseases in-
cluded in each pattern varied by sex; women had a
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higher number of diseases than men, although there was
a high coincidence (matching) between them in the type
of diseases grouped.
The clusters were sorted in descending order by num-
ber of individuals included. The first cluster included
about 40% of the population (40.7% of women and
38.7% of men) and no O/E ratio higher than 2 was ob-
served in these first clusters. In these first clusters, the
highest exclusivity value was 46.1% for Mental and
behavioural disorders due to psychoactive substance
use (tobacco) in women and 35.3% for Metabolic
disorders in men.
The most prevalent cluster included coincident dis-
eases in both men and women: Metabolic disorders,
Hypertensive diseases, Mental and behavioural disorders
due to psychoactive substance use, Other dorsopathies
and Other soft tissue disorders (Tables 2 and 3).
Four other patterns were almost coincident between
the sexes: 1) Cluster 4 (women) and cluster 3 (men),
composed mostly of diseases of the digestive and muscu-
loskeletal system; 2) Cluster 2 (women) and Cluster 4
(men), connective tissue diseases; 3) Cluster 5 was com-
posed of a cardiometabolic pattern (obesity, hyperten-
sion and diabetes) in both groups; and 4) Cluster 6,
infectious and injurious diseases (see Tables 2 and 3). O/
E ratios varied for each cluster, peaking at 8.99 for Other
viral diseases and 8.24 for Other acute lower respiratory
infections in cluster 6 (women) (Tables 2 and 3).
In both sexes, the most prevalent multimorbidity pat-
tern in the oldest patients (Tables 2 and 3) were musculo-
skeletal system and connective tissue diseases in women
(mean age: 57.4) and cardiometabolic pattern (obesity,
hypertension, and diabetes) in men (mean age: 57.1).
Multimorbidity patterns considering only blocks of
diagnoses with O/E ratio ≥ 2, ordered by exclusivity in
women and men, showed that the highest exclusivity in
women was observed in Cluster 6: 83.9% of the people
who had a diagnosis of Other viral diseases are included
in this cluster. They were followed by Cluster 5, which
77.0% of people with Diabetes mellitus belonged to. In
men, 83.7% of people with Disorders of choroid and
retina belongs to Cluster 5, and 77.6%, which includes
Viral hepatitis, in Cluster 2 (Additional file 4).
Discussion
Non-hierarchical cluster analysis yielded an informative
categorization of patients, generating reasonable multi-
morbity patterns from a clinical, practical perspective,
and identified phenotypes for sub-groups of patients.
Metabolic-circulatory-tobacco use-musculoskeletal pat-
tern is the most common multimorbidity pattern
Table 1 Number of diseases for patients 45–64 years old,
stratified by sex, Catalonia, 2010*
Women
n (%)
217,823 (82.2)
Men
n (%)
191,171 (73.9)
Number of diagnoses†
2 26,106 (12.0) 33,850 (17.7)
3 28,243 (13.0) 33,515 (17.5)
4 28,274 (13.0) 30,356 (15.9)
≥ 5 135,200 (62.1) 93,450 (48.9)
Median number of diagnoses (IQR)‡ 5 (4–8) 4 (3–7)
Number of diagnoses included 79 73
Abbreviations: IQR inter-quartile range
*Included in the analysis N = 523,656, people with ≥2 diagnoses; 408,994 (78.1%)
†Two sample test of proportions; all p-values< 0.001
‡Mann-Whitney test; P < 0.001
Fig. 1 a and b. Patients cluster plot for women (n = 217,823) and men (n = 191,171) aged 45–64 years, analysed with k-means clustering
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Table 2 Three most prevalent multimorbidity patterns in women (n = 217,823) aged 45–65 years, Catalonia, 2010
Cluster
n (%)a
Blocks of diagnoses Prevalence in
cluster (%)b
Prevalence
in women
(%)c
O/E ratiod Exclusivity
(%)
Centrality Mean
Age
Median
number of
diagnoses
1 E70-E90:Metabolic disorders 25.9 35.4 0.73 29.8 0.8 53.0 3
88,657 (40.7) M50-M54:Other dorsopathies 23.6 35.8 0.66 26.9
F10-F19:Mental and behavioural
disorders due to psychoactive
substance use
21.1 18.6 1.13 46.1
F40-F48:Neurotic. stress-related
and somatoform disorders
20.0 27.3 0.73 29.9
N80-N98:Noninflammatory
disorders of female genital tract
17.6 24.2 0.73 29.6
I10-I15:Hypertensive diseases 15.6 25.6 0.61 24.9
M70-M79:Other soft tissue
disorders
13.9 27.0 0.52 21.0
E00-E07:Disorders of thyroid
gland
11.8 14.9 0.79 32.3
D10-D36:Benign neoplasms 10.4 16.2 0.65 26.3
2 M50-M54:Other dorsopathies 55.4 35.8 1.55 23.0 1.6 57.4 7
32,249 (14.8) E70-E90:Metabolic disorders 53.6 35.4 1.52 22.4
M15-M19:Arthrosis 48.2 15.7 3.08 45.6
M70-M79:Other soft tissue
disorders
47.5 27.0 1.76 26.1
M80-M85:Disorders of bone
density and structure
38.7 11.3 3.41 50.5
M20-M25:Other joint disorders 33.0 18.6 1.78 26.3
F40-F48:Neurotic. stress-related
and somatoform disorders
30.1 27.3 1.10 16.3
I10-I15:Hypertensive diseases 29.3 25.6 1.14 16.9
I80-I89:Diseases of veins.
Lymphatic vessels and lymph
nodes. Not elsewhere classified
29.2 18.3 1.60 23.7
F30-F39:Mood [affective] disorders 20.8 14.6 1.43 21.1
N80-N98:Noninflammatory
disorders of female genital tract
20.5 24.2 0.85 12.5
E65-E68:Obesity and other
hyperalimentation
20.5 19.0 1.08 16.0
G50-G59:Nerve. nerve root and
plexus disorders
20.0 8.5 2.34 34.7
M45-M49:Spondylopathies 19.7 4.3 4.56 67.4
E00-E07:Disorders of thyroid
gland
17.8 14.9 1.20 17.7
M40-M43:Deforming
dorsopathies
15.1 3.8 3.96 58.6
D10-D36:Benign neoplasms 12.4 16.2 0.77 11.4
K20-K31:Diseases of oesophagus.
Stomach and duodenum
12.0 11.4 1.05 15.6
J30-J39:Other diseases of upper
respiratory tract
11.2 9.4 1.19 17.6
G40-G47:Episodic and paroxysmal
disorders
11.2 10.5 1.06 15.7
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Table 2 Three most prevalent multimorbidity patterns in women (n = 217,823) aged 45–65 years, Catalonia, 2010 (Continued)
Cluster
n (%)a
Blocks of diagnoses Prevalence in
cluster (%)b
Prevalence
in women
(%)c
O/E ratiod Exclusivity
(%)
Centrality Mean
Age
Median
number of
diagnoses
J00-J06:Acute upper respiratory
infections
11.1 12.6 0.88 13.0
H90-H95:Other disorders of ear 10.2 6.3 1.60 23.7
3 N80-N98:Noninflammatory
disorders of female genital tract
48.1 24.2 1.99 25.6 1.7 53.0 8
28,024 (12.9) M50-M54:Other dorsopathies 46.9 35.8 1.31 16.9
M70-M79:Other soft tissue
disorders
38.8 27.0 1.44 18.5
M20-M25:Other joint disorders 33.6 18.6 1.81 23.3
D10-D36:Benign neoplasms 32.8 16.2 2.03 26.1
I80-I89:Diseases of veins.
Lymphatic vessels and lymph
nodes. Not elsewhere classified
29.3 18.3 1.60 20.6
L20-L30:Dermatitis and eczema 28.4 9.3 3.05 39.2
E70-E90:Metabolic disorders 27.7 35.4 0.78 10.1
F40-F48:Neurotic. stress-related
and somatoform disorders
26.3 27.3 0.96 12.4
K00-K14:Diseases of oral cavity.
Salivary glands and jaws
23.3 12.1 1.93 24.9
B35-B49:Mycoses 19.8 5.7 3.46 44.5
D50-D53:Nutritional anaemias 19.7 8.3 2.38 30.6
N60-N64:Disorders of breast 19.2 7.5 2.56 32.9
J00-J06:Acute upper respiratory
infections
16.9 12.6 1.34 17.2
H53-H54:Visual disturbances
and blindness
16.8 4.4 3.84 49.4
E00-E07:Disorders of thyroid
gland
16.7 14.9 1.13 14.5
L60-L75:Disorders of skin
appendages
16.7 4.8 3.51 45.2
I10-I15:Hypertensive diseases 15.9 25.6 0.62 8.0
E65-E68:Obesity and other
hyperalimentation
15.4 19.0 0.81 10.4
J30-J39:Other diseases of upper
respiratory tract
15.2 9.4 1.61 20.8
G40-G47:Episodic and paroxysmal
disorders
14.0 10.5 1.33 17.1
B00-B09:Viral infections
characterized by skin and
mucous membrane lesions
13.9 4.3 3.21 41.2
H90-H95:Other disorders of ear 12.9 6.3 2.03 26.2
H49-H52:Disorders of ocular
muscles. Binocular movement.
Accommodation and refraction
12.9 3.5 3.64 46.8
L80-L99:Other disorders of the
skin and subcutaneous tissue
12.8 3.3 3.83 49.3
H10-H13:Disorders of
conjunctiva
12.2 3.8 3.21 41.3
F30-F39:Mood [affective] disorders 11.7 14.6 0.80 10.3
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identified by NHCA in both sexes. This pattern would
be classified as nonspecific because it had the lowest
centrality value (0.8 for both sexes). It is the most com-
mon in the population with multimorbidity aged 45–
65 years. This pattern seems to be consistent with other
studies which obtained similar associations of diseases
with other methods of analysis [2, 3].
Other data of interest are the higher exclusivity values
obtained in some clusters. For example, 77% of women
who suffered diabetes mellitus have other associated dis-
eases, such as forms of heart disease, obesity, and hyper-
tension. These results are similar to the report from
Hughes et al. that 71% of people with diabetes had mul-
timorbidity [19]. Other coexisting diseases in the 84% of
men who had disorders of choroid and retina (ischemic
heart diseases, diseases of arteries, arterioles and capil-
laries, diabetes, other forms of heart disease, obesity, and
hypertension) reflect a broad affectation of the vascular
tree. Another remarkable observation in some patterns
was the clustering of diseases of the same system or the
presence of diseases, reflecting a complication. For ex-
ample, one multimorbidity pattern consisted of seven
diseases, of which five were diseases of the musculoskel-
etal system and connective tissue (Cluster 2, women).
Another well-known example is the complications of
diabetes mellitus such as disorders of choroid and retina
(diabetic retinopathy) and renal failure (Cluster 5, men).
These results can be translated into clinical practice.
When a disease is first diagnosed, we can suspect other
associated diseases. Clinical practice guidelines could
orient their recommendations toward these sub-groups
(for example: arthritis, anxiety and depression). On the
other hand, some results could be difficult to interpret
in the context of current knowledge. Some patterns ob-
tained included many diseases with no apparent connec-
tion between them.
In general, it is difficult to compare our results with
the findings of other studies because of variations in
methods, data sources and structures, populations, and
diseases studied. However, there are some similarities
between the current study and others. The first pattern
is similar to the cardio-metabolic pattern reported by
Prados et al. in adults aged 45 to 64 years (hypertension,
diabetes, obesity, and lipid metabolism disorders) with
an exploratory factor analysis [6]. In participants older
than 50 years, another study found a cardiorespiratory
factor (angina, asthma, and chronic lung disease) quite
similar to our Cluster 5 in men and a mental-arthritis
factor (arthritis, anxiety and depression) similar to our
Cluster 2 in women [20].
The major strength of this study is the large,
high-quality population database of primary care records
that have been shown to be representative of a much lar-
ger population [13]. The analysis was stratified by sex
and a patient-level perspective was used with NHCA.
Admittedly, this analysis of almost all potential diagno-
ses may have added a complexity that will hinder inter-
pretation of findings and comparison with other studies.
Another major strength of this study was the operational
definition of multimorbidity as the co-occurrence of
multiple chronic or acute diseases [21] which allows the
inclusion of the full range of diseases observed in any
one patient. This is especially relevant because the
boundaries between chronic and acute disease are not
always clear [22, 23]. The strengths of using K-means
cluster analysis is that the results are less susceptible to
outliers in the data, the influence of chosen distance
measure, or the inclusion of inappropriate or irrelevant
variables [10]. The method can also analyse extremely
large data sets as in our study, as no distance matrix is
required. Some disadvantages of the method are that
different solutions for each set of seed points can
occur and there is no guarantee of optimal clustering
[12]. To minimize this shortcoming, we tested the
internal validity of our solution using bootstrap
methods, and the results were highly stable (Jaccard>
0.85) [17]. In addition, the method is not efficient
when a large number of potential cluster solutions
are to be considered [10]; to address this limitation,
we computed the optimal number using analytical in-
dexes like Calinski Harabasz [24].
A number of limitations need to be taken into account
as well. The use of MCA can produce low percentages
of variation on principal axes and make it difficult to
choose the number of dimensions to retain. We assumed
a 5-dimension solution using the elbow rule in the scree
Table 2 Three most prevalent multimorbidity patterns in women (n = 217,823) aged 45–65 years, Catalonia, 2010 (Continued)
Cluster
n (%)a
Blocks of diagnoses Prevalence in
cluster (%)b
Prevalence
in women
(%)c
O/E ratiod Exclusivity
(%)
Centrality Mean
Age
Median
number of
diagnoses
K55-K63:Other diseases of
intestines
11.3 8.6 1.32 17.0
M15-M19:Arthrosis 11.1 15.7 0.71 9.2
K20-K31:Diseases of oesophagus.
Stomach and duodenum
10.3 11.4 0.91 11.7
aIndividuals (% of total women) / bIndividuals as % of cluster / cIndividuals as % of total women)
dObserved / Expected Ratio. Values ≥2 in bold
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Table 3 Three most prevalent multimorbidity patterns in men (n = 191,171) aged 45–65 years, Catalonia, 2010
Cluster
n (%)a
Blocks of diagnoses Prevalence in
cluster (%)b
Prevalence in
men (%)c
O/E ratiod Exclusivity
(%)
Centrality Mean
Age
Median
number of
diagnoses
1 E70-E90:Metabolic disorders 38.4 42.2 0.91 35.3 0.8 53.3 3
73,979 (38.7) I10-I15:Hypertensive diseases 28.1 32.5 0.86 33.4
F10-F19:Mental and
behavioural disorders due to
psychoactive substance use
25.4 33.6 0.76 29.2
M50-M54:Other dorsopathies 20.8 27.8 0.75 28.9
M70-M79:Other soft tissue
disorders
10.7 16.9 0.63 24.6
E65-E68:Obesity and other
hyperalimentation
10.6 14.6 0.73 28.2
2 F10-F19:Mental and
behavioural disorders due
to psychoactive substance
use
77.3 33.6 2.30 34.9 1.5 52.6 4
28,951 (15.1) E70-E90:Metabolic disorders 26.4 42.2 0.63 9.5
F40-F48:Neurotic. stress-related
and somatoform disorders
25.1 13.5 1.86 28.1
M50-M54:Other dorsopathies 23.7 27.8 0.85 12.9
K00-K14:Diseases of oral cavity.
Salivary glands and jaws
23.2 12.0 1.93 29.2
J40-J47:Chronic lower
respiratory diseases
19.4 9.3 2.09 31.6
F30-F39:Mood [affective]
disorders
17.0 6.3 2.72 41.2
B15-B19:Viral hepatitis 16.6 3.2 5.13 77.6
I10-I15:Hypertensive diseases 14.2 32.5 0.44 6.6
K70-K77:Diseases of liver 12.5 5.2 2.38 36.1
K20-K31:Diseases of
oesophagus. Stomach and
duodenum
12.3 11.5 1.06 16.1
M70-M79:Other soft tissue
disorders
10.4 16.9 0.62 9.4
3 E70-E90:Metabolic disorders 43.4 42.2 1.03 12.1 1.9 55.2 6
22,458 (11.8) K20-K31:Diseases of
oesophagus. Stomach and
duodenum
40.0 11.5 3.47 40.7
K40-K46:Hernia 31.3 8.8 3.57 41.9
N40-N51:Diseases of male
genital organs
30.9 12.1 2.54 29.9
I10-I15:Hypertensive diseases 30.3 32.5 0.93 10.9
M50-M54:Other dorsopathies 29.6 27.8 1.06 12.5
I80-I89:Diseases of veins.
Lymphatic vessels and
lymph nodes. Not elsewhere
classified
29.6 10.0 2.95 34.7
K55-K63:Other diseases of
intestines
28.2 6.4 4.39 51.6
D10-D36:Benign neoplasms 21.1 8.6 2.46 28.9
F10-F19:Mental and
behavioural disorders due to
psychoactive substance use
20.8 33.6 0.62 7.3
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plot to achieve the most accurate solution possible with-
out including too many dimensions in the analysis [16].
In some clusters, an accumulative diagnosis belonging to
the same chapter could be coded in multiple ways; how-
ever, use of the structure of ICD10 3-character codes
that group diseases as the unit of analysis, rather than
the more specific individual diagnosis, makes this
improbable.
Few studies have focused on the MM patterns in pa-
tients rather than on diseases [25–27]. This methodology
produced results that can be transferred to clinical prac-
tice, as they suggested that diseases are not equally asso-
ciated with all phenotypes and there may be a genetic
basis for patterns of multimorbidity.
Multimorbidity can present a problem for health ser-
vices delivery, affecting patients, health professionals,
and managers who are attempting to improve service
delivery [28]. Our study offers a new methodological ap-
proach to understanding the relationships between spe-
cific diseases in individual patients, which is an essential
step in improving the care of patients and health systems
in organizations. Analysing patient profiles permitted
the identification of subgroups of patients with different
associated diseases.
This study illustrates the need to pay careful attention
to the methods used to support policies and
decision-making. The study results have implications for
three fundamental areas of action: a) the need to change
the orientation of clinical guidelines that focus on a sin-
gle disease; b) the need to change health policy that is
based on a disease rather than on the whole person; and
c) the need to change current incentive policies that
focus the health professional’s attention on a disease ra-
ther than on multimorbidity, which includes not only
diseases but also drug interactions, polypharmacy and
the process of patient-health professional interactions.
Future studies on the current topic are therefore rec-
ommended, with a special focus on three major issues.
First, the genetic typing of these multimorbidity patterns
will identify genetic confluence in these patterns.
Second, the delimitation of environment factors (alimen-
tation, physical exercise, toxicity, etc.) associated with
these patterns. Third, longitudinal studies should be
done to establish the order of disease onset. Finally, the
influence of polypharmacy, or the use of multiple drugs,
could decrease treatment efficacy and cause unexpected
adverse events or even the development of other dis-
eases [29, 30].
These findings suggest that multimorbidity patterns
obtained using non-hierarchical cluster analysis identi-
fied clusters more consistent with clinical practice, iden-
tifying phenotypes of certain sub-groups of patients.
Conclusion
Non-hierarchical cluster analysis identified multimorbid-
ity patterns consistent with clinical practice, identifying
phenotypic subgroups of patients.
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Table 3 Three most prevalent multimorbidity patterns in men (n = 191,171) aged 45–65 years, Catalonia, 2010 (Continued)
Cluster
n (%)a
Blocks of diagnoses Prevalence in
cluster (%)b
Prevalence in
men (%)c
O/E ratiod Exclusivity
(%)
Centrality Mean
Age
Median
number of
diagnoses
F40-F48:Neurotic. stress-related
and somatoform disorders
19.7 13.5 1.46 17.2
J30-J39:Other diseases of
upper respiratory tract
16.1 8.0 2.01 23.6
M70-M79:Other soft tissue
disorders
15.6 16.9 0.92 10.9
G40-G47:Episodic and
paroxysmal disorders
13.1 7.4 1.77 20.8
N20-N23:Urolithiasis 13.0 4.3 3.00 35.3
J40-J47:Chronic lower
respiratory diseases
12.0 9.3 1.29 15.1
H90-H95:Other disorders of ear 10.8 7.7 1.40 16.5
aIndividuals (% of total men) / bIndividuals as % of the cluster /cIndividuals as % of total men
dObserved / Expected Ratio. Values ≥2 in bold
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